P/E (Trailing) ~2.4 - 2.9 Extremely low. The market values the company with a huge "China risk".
Forward P/E ~2.9 Earnings are expected to remain stable, but without a major breakthrough.
ROE ~18.7% (Proj.) Good return on equity, but the trend is downward.
Dividend Yield ~8.5% - 9.0% High dividend, supported by an active share buyback program.
Asset Quality 2.02% (90+ day delinquency) Bad credit risk remains under control, but is being closely monitored.
Analyst Rating Strong Buy Most analysts (12 out of 13) give a "Buy" rating due to the low valuation.
Intrinsic Value: According to DCF models, the stock is over 300% undervalued, with a fair value estimated at around $75 - $80, while the market price is currently around $16.70.
Institutional Movements (Q3/Q4 2025): There has been a massive outflow of large hedge funds. AllianceBernstein and Goldman Sachs have reduced their positions significantly (-97% and -68%), while Krane Funds has added shares (+25%).
Forward P/E ~2.9 Earnings are expected to remain stable, but without a major breakthrough.
ROE ~18.7% (Proj.) Good return on equity, but the trend is downward.
Dividend Yield ~8.5% - 9.0% High dividend, supported by an active share buyback program.
Asset Quality 2.02% (90+ day delinquency) Bad credit risk remains under control, but is being closely monitored.
Analyst Rating Strong Buy Most analysts (12 out of 13) give a "Buy" rating due to the low valuation.
Intrinsic Value: According to DCF models, the stock is over 300% undervalued, with a fair value estimated at around $75 - $80, while the market price is currently around $16.70.
Institutional Movements (Q3/Q4 2025): There has been a massive outflow of large hedge funds. AllianceBernstein and Goldman Sachs have reduced their positions significantly (-97% and -68%), while Krane Funds has added shares (+25%).
Disclaimer
The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.
Disclaimer
The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.